Linked e-resources
Details
Table of Contents
Best Practices: Position &
Guidance Documents of ASHP
Title page
Copyright
Contents
Page Locator for Guidance Documents by Type and Title
Introduction
Mission Statement
Vision Statement
Automation and Information Technology
Positions:
*2303 - Interoperability of Patient-Care Technologies
*2304 - Patient Medication Delivery Systems
*2332 - Barcoding of Lot Number and Expiration Date
*2204 - Mobile Health Tools, Clinical Apps, and Associated Devices
*2246 - Autoverification of Medication Orders
*2255 - Therapeutic Indication for Prescribed Medications
*2147 - Pharmacist's Role in Healthcare Information Systems
*2015 - Network Connectivity and Interoperability for Continuity of Care
1529 - Online Pharmacy and Internet Prescribing
1418 - Risk Assessment of Health Information Technology
*1212 - Clinical Decision Support Systems
1020 - Role of Pharmacists in Safe Technology Implementation
0712 - Electronic Health and Business Technology and Services
0105 - Computerized Prescriber Order Entry
9813 - Regulation of Automated Drug Distribution Systems
Statements:
Bar-Code-Enabled Medication Administration Technology
Bar-Code Verification During Inventory, Preparation, and Dispensing of Medications
Pharmacist's Role in Clinical Informatics
Pharmacist's Role with Respect to Drug Delivery Systems and Administration Devices
*Pharmacy Technician's Role in Pharmacy Informatics
*Telehealth Pharmacy Practice
*Use of Artificial Intelligence in Pharmacy
Use of Social Media by Pharmacy Professionals
Guidelines:
Design of Database-Driven Clinical Decision Support: Strategic Directions for Drug Database and Electronic Health Records Vendors
Pharmacy Planning for Implementation of CPOE Systems in Hospitals and Health Systems.
Remote Medication Order Processing
*Safe Use of Automated Compounding Devices for the Preparation of Parenteral Nutrition Admixtures
*Safe Use of Automated Dispensing Cabinets
Drug Distribution and Control Positions:
Positions:
*2222 - Pharmacist's Role in Medication Procurement, Distribution, Surveillance, and Control
*2145 - Reduction of Unused Prescription Drug Products
2042 - Controlled Substances Diversion Prevention
0303 - Pharmacy Drug Theft
9903 - Optimizing the Medication-Use Process
Guideline:
*Preventing Diversion of Controlled Substances
PROCUREMENT
Guidelines:
Managing Drug Product Shortages
Selecting Pharmaceutical Manufacturers and Suppliers
PREPARATION AND HANDLING
Positions:
*2139 - Safe and Effective Extemporaneous Compounding
*2024 - Safety and Efficacy of Compounded Topical Formulations
1903 - Compounded Sterile Preparation Verification
1813 - Use of Closed-System Transfer Devices to Reduce Drug Waste
0903 - Pharmaceutical Waste
0614 - Safe Disposal of Patients' Home Medications
Guidelines:
Compounding Sterile Preparations
Handling Hazardous Drugs
TAB:
Compounding Nonsterile Products in Pharmacies
DISTRIBUTION
Positions:
*2022 - Dispensing by Nonpharmacists and Nonprescribers
1913 - Pharmaceutical Distribution Systems
*0310 - Technician-Checking-Technician Programs
Statements:
Pharmacist's Responsibility for Distribution and Control of Drug Products
Unit Dose Drug Distribution
TABs:
Hospital Drug Distribution and Control
Repackaging Oral Solids and Liquids in Single Unit and Unit Dose Packages
Single Unit and Unit Dose Packages of Drugs
Education and Training
Positions:
2301 - Education and Training in Digital Health
2329 - Well-Being and Resilience of the Pharmacy Workforce.
*2201 - State-Specific Requirements for Pharmacist and Pharmacy Technician Continuing Education
*2203 - Preceptor Skills and Abilities
*2216 - Career Counseling
*2230 - Advancing Diversity, Equity, and Inclusion in Education and Training
*2231 - Cultural Competency
*2104 - Fostering Leadership Development
*2105 - Interprofessional Education and Training
*2106 - Pharmacy Education and Training Models
*2107 - Pharmacy Internships
*2027 - Residency Training for Pharmacists Who Provide Direct Patient Care
1911 - Pharmacy Expertise in Sterile Compounding
1912 - Pharmacy Technician Training and Certification
1917 - Pharmacy Technician Student Drug Testing
1918 - Minimum Educational Qualification Standards for Pharmacists
*1826 - Student Pharmacist Drug Testing
1827 - Collaboration on Experiential Education
1706 - ASHP Guidelines, Statements, and Professional Policies as an Integral Part of the Educational Process
1317 - Education and Training in Health Care Informatics
1203 - Qualifications of Pharmacy Technicians in Advanced Roles
1108 - Quality of Pharmacy Education and Expansion of Colleges of Pharmacy
1109 - Residency Equivalency
1112 - Innovative Residency Models
1008 - Employment Classification and Duty Hours of Pharmacy Residents
0913 - Pharmacy Student Experiences in Medically Underserved Areas
0916 - Continuing Professional Development
0917 - Pharmacy Residency Training
0704 - Residency Programs
0510 - Communication Among Health-System Pharmacy Practitioners, Patients, and Other Health Care Providers
0325 - Public Funding for Pharmacy Residency Training
Statement:
*Precepting as a Professional Obligation
Endorsed:
Definitions of Pharmacy Residencies and Fellowships
Ethics
Positions:
*2320 - Pharmacoequity.
*2036 - Racial and Discriminatory Inequities
1704 - Medical Aid in Dying
1531 - Pharmacist Role in Capital Punishment
1403 - Pharmacist's Role on Ethics Committees
1116 - Ethical Use of Placebos in Clinical Practice
0610 - Pharmacist's Right of Conscience and Patient's Right of Access to Therapy
0013 - Patient's Right to Choose
Statements:
*Leadership as a Professional Obligation
Pharmacist's Decision-making on Assisted Suicide
*Professionalism
Guideline:
Pharmacists' Relationships with Industry
Endorsed:
Code of Ethics for Pharmacists
Formulary Management (Medication-Use Policy Development)
Positions:
*2308 - Pharmacogenomics
*2016 - Medication Formulary System Management
*1802 - Gene Therapy
1820 - Medical Devices
0817 - Generic Substitution of Narrow Therapeutic Index Drugs
8708 - Therapeutic Interchange
Statement:
Use of Medications for Unlabeled Uses
Guidelines:
*Medication-Use Evaluation
*Pharmacy and Therapeutics Committee and the Formulary System
Endorsed:
Principles of a Sound Drug Formulary System
Government, Law, and Regulation
Positions:
*2306 - Support for FDA Expanded Access (Compassionate Use) Program
*2307 - Biosimilar Medications
*2317 - Emergency Medical Kits
*2322 - Availability and Use of Fentanyl Test Strips
*2323 - DEA Scheduling of Controlled Substances
*2325 - Nonprescription Availability of Self-Administered Influenza Antivirals
*2326 - Over-the-Counter Availability of Hormonal Contraceptives
*2330 - Pharmacist Prescribing Authority for Antiretroviral Therapy for the Prevention of HIV/AIDS
*2239 - Drug Pricing Proposals
*2101 - Direct-to-Consumer Clinical Genetic Tests
*2111 - Pharmacist Involvement in the Strategic National Stockpile
*2112 - Medication Price-Gouging Laws.
*2114 - FDA Requirement for Dose-Response Information
*2115 - Medical Cannabis
*2118 - Supply Chain Resilience During Disasters and Public Health Emergencies
*2141 - Pharmacist Engagement in and Payment for Telehealth
*2142 - Pharmacy Services in a State of Emergency
*2144 - Agricultural Use of Hormone and Prohormone Therapy
*2004 - Evaluation of Abuse-Deterrent Drug Mechanisms
*2005 - Quality Consumer Medication Information
*2007 - Use of Surrogate Endpoints for FDA Approval of Drug Uses
*2012 - Importation of Drug Products
*2013 - Public Quality Standards for Biologic Products
*2019 - Access to Affordable Healthcare
*2021 - Funding, Expertise, and Oversight of State Boards of Pharmacy
*2023 - New Categories of Licensed Pharmacy Personnel
*2025 - Postmarketing Studies
*2026 - Gabapentin as a Controlled Substance
*2030 - Interstate Pharmacist Licensure
*2037 - Support of the World Health Organization
*2040 - Premarketing Comparative Clinical Studies
*2043 - Drug Product Supply Chain Integrity
1904 - Notification of Drug Product Price Increases
1905 - Mitigating Drug Product Shortages
1906 - Emergency Supplies of Drug Products
1908 - 340B Drug Pricing Program Sustainability
1909 - Pharmacist Authority to Provide Medication-Assisted Treatment
1922 - Antimicrobial Use in Agriculture
*1803 - Confidence in the U.S. Drug Approval and Regulatory Process
1815 - Impact of Drug Litigation Ads on Patient Care
*1818 - Federal Quality Rating Program for Pharmaceutical Manufacturers
1819 - Intravenous Fluid Manufacturing Facilities as Critical Public Health Infrastructure
1713 - Partial Filling of Schedule II Prescriptions
1715 - Collaborative Practice
1716 - Greater Competition Among Generic and Biosimilar Manufacturers
1621 - Timely Board of Pharmacy Licensing.
1501 - Pharmacist Participation in Health Policy Development.
Guidance Documents of ASHP
Title page
Copyright
Contents
Page Locator for Guidance Documents by Type and Title
Introduction
Mission Statement
Vision Statement
Automation and Information Technology
Positions:
*2303 - Interoperability of Patient-Care Technologies
*2304 - Patient Medication Delivery Systems
*2332 - Barcoding of Lot Number and Expiration Date
*2204 - Mobile Health Tools, Clinical Apps, and Associated Devices
*2246 - Autoverification of Medication Orders
*2255 - Therapeutic Indication for Prescribed Medications
*2147 - Pharmacist's Role in Healthcare Information Systems
*2015 - Network Connectivity and Interoperability for Continuity of Care
1529 - Online Pharmacy and Internet Prescribing
1418 - Risk Assessment of Health Information Technology
*1212 - Clinical Decision Support Systems
1020 - Role of Pharmacists in Safe Technology Implementation
0712 - Electronic Health and Business Technology and Services
0105 - Computerized Prescriber Order Entry
9813 - Regulation of Automated Drug Distribution Systems
Statements:
Bar-Code-Enabled Medication Administration Technology
Bar-Code Verification During Inventory, Preparation, and Dispensing of Medications
Pharmacist's Role in Clinical Informatics
Pharmacist's Role with Respect to Drug Delivery Systems and Administration Devices
*Pharmacy Technician's Role in Pharmacy Informatics
*Telehealth Pharmacy Practice
*Use of Artificial Intelligence in Pharmacy
Use of Social Media by Pharmacy Professionals
Guidelines:
Design of Database-Driven Clinical Decision Support: Strategic Directions for Drug Database and Electronic Health Records Vendors
Pharmacy Planning for Implementation of CPOE Systems in Hospitals and Health Systems.
Remote Medication Order Processing
*Safe Use of Automated Compounding Devices for the Preparation of Parenteral Nutrition Admixtures
*Safe Use of Automated Dispensing Cabinets
Drug Distribution and Control Positions:
Positions:
*2222 - Pharmacist's Role in Medication Procurement, Distribution, Surveillance, and Control
*2145 - Reduction of Unused Prescription Drug Products
2042 - Controlled Substances Diversion Prevention
0303 - Pharmacy Drug Theft
9903 - Optimizing the Medication-Use Process
Guideline:
*Preventing Diversion of Controlled Substances
PROCUREMENT
Guidelines:
Managing Drug Product Shortages
Selecting Pharmaceutical Manufacturers and Suppliers
PREPARATION AND HANDLING
Positions:
*2139 - Safe and Effective Extemporaneous Compounding
*2024 - Safety and Efficacy of Compounded Topical Formulations
1903 - Compounded Sterile Preparation Verification
1813 - Use of Closed-System Transfer Devices to Reduce Drug Waste
0903 - Pharmaceutical Waste
0614 - Safe Disposal of Patients' Home Medications
Guidelines:
Compounding Sterile Preparations
Handling Hazardous Drugs
TAB:
Compounding Nonsterile Products in Pharmacies
DISTRIBUTION
Positions:
*2022 - Dispensing by Nonpharmacists and Nonprescribers
1913 - Pharmaceutical Distribution Systems
*0310 - Technician-Checking-Technician Programs
Statements:
Pharmacist's Responsibility for Distribution and Control of Drug Products
Unit Dose Drug Distribution
TABs:
Hospital Drug Distribution and Control
Repackaging Oral Solids and Liquids in Single Unit and Unit Dose Packages
Single Unit and Unit Dose Packages of Drugs
Education and Training
Positions:
2301 - Education and Training in Digital Health
2329 - Well-Being and Resilience of the Pharmacy Workforce.
*2201 - State-Specific Requirements for Pharmacist and Pharmacy Technician Continuing Education
*2203 - Preceptor Skills and Abilities
*2216 - Career Counseling
*2230 - Advancing Diversity, Equity, and Inclusion in Education and Training
*2231 - Cultural Competency
*2104 - Fostering Leadership Development
*2105 - Interprofessional Education and Training
*2106 - Pharmacy Education and Training Models
*2107 - Pharmacy Internships
*2027 - Residency Training for Pharmacists Who Provide Direct Patient Care
1911 - Pharmacy Expertise in Sterile Compounding
1912 - Pharmacy Technician Training and Certification
1917 - Pharmacy Technician Student Drug Testing
1918 - Minimum Educational Qualification Standards for Pharmacists
*1826 - Student Pharmacist Drug Testing
1827 - Collaboration on Experiential Education
1706 - ASHP Guidelines, Statements, and Professional Policies as an Integral Part of the Educational Process
1317 - Education and Training in Health Care Informatics
1203 - Qualifications of Pharmacy Technicians in Advanced Roles
1108 - Quality of Pharmacy Education and Expansion of Colleges of Pharmacy
1109 - Residency Equivalency
1112 - Innovative Residency Models
1008 - Employment Classification and Duty Hours of Pharmacy Residents
0913 - Pharmacy Student Experiences in Medically Underserved Areas
0916 - Continuing Professional Development
0917 - Pharmacy Residency Training
0704 - Residency Programs
0510 - Communication Among Health-System Pharmacy Practitioners, Patients, and Other Health Care Providers
0325 - Public Funding for Pharmacy Residency Training
Statement:
*Precepting as a Professional Obligation
Endorsed:
Definitions of Pharmacy Residencies and Fellowships
Ethics
Positions:
*2320 - Pharmacoequity.
*2036 - Racial and Discriminatory Inequities
1704 - Medical Aid in Dying
1531 - Pharmacist Role in Capital Punishment
1403 - Pharmacist's Role on Ethics Committees
1116 - Ethical Use of Placebos in Clinical Practice
0610 - Pharmacist's Right of Conscience and Patient's Right of Access to Therapy
0013 - Patient's Right to Choose
Statements:
*Leadership as a Professional Obligation
Pharmacist's Decision-making on Assisted Suicide
*Professionalism
Guideline:
Pharmacists' Relationships with Industry
Endorsed:
Code of Ethics for Pharmacists
Formulary Management (Medication-Use Policy Development)
Positions:
*2308 - Pharmacogenomics
*2016 - Medication Formulary System Management
*1802 - Gene Therapy
1820 - Medical Devices
0817 - Generic Substitution of Narrow Therapeutic Index Drugs
8708 - Therapeutic Interchange
Statement:
Use of Medications for Unlabeled Uses
Guidelines:
*Medication-Use Evaluation
*Pharmacy and Therapeutics Committee and the Formulary System
Endorsed:
Principles of a Sound Drug Formulary System
Government, Law, and Regulation
Positions:
*2306 - Support for FDA Expanded Access (Compassionate Use) Program
*2307 - Biosimilar Medications
*2317 - Emergency Medical Kits
*2322 - Availability and Use of Fentanyl Test Strips
*2323 - DEA Scheduling of Controlled Substances
*2325 - Nonprescription Availability of Self-Administered Influenza Antivirals
*2326 - Over-the-Counter Availability of Hormonal Contraceptives
*2330 - Pharmacist Prescribing Authority for Antiretroviral Therapy for the Prevention of HIV/AIDS
*2239 - Drug Pricing Proposals
*2101 - Direct-to-Consumer Clinical Genetic Tests
*2111 - Pharmacist Involvement in the Strategic National Stockpile
*2112 - Medication Price-Gouging Laws.
*2114 - FDA Requirement for Dose-Response Information
*2115 - Medical Cannabis
*2118 - Supply Chain Resilience During Disasters and Public Health Emergencies
*2141 - Pharmacist Engagement in and Payment for Telehealth
*2142 - Pharmacy Services in a State of Emergency
*2144 - Agricultural Use of Hormone and Prohormone Therapy
*2004 - Evaluation of Abuse-Deterrent Drug Mechanisms
*2005 - Quality Consumer Medication Information
*2007 - Use of Surrogate Endpoints for FDA Approval of Drug Uses
*2012 - Importation of Drug Products
*2013 - Public Quality Standards for Biologic Products
*2019 - Access to Affordable Healthcare
*2021 - Funding, Expertise, and Oversight of State Boards of Pharmacy
*2023 - New Categories of Licensed Pharmacy Personnel
*2025 - Postmarketing Studies
*2026 - Gabapentin as a Controlled Substance
*2030 - Interstate Pharmacist Licensure
*2037 - Support of the World Health Organization
*2040 - Premarketing Comparative Clinical Studies
*2043 - Drug Product Supply Chain Integrity
1904 - Notification of Drug Product Price Increases
1905 - Mitigating Drug Product Shortages
1906 - Emergency Supplies of Drug Products
1908 - 340B Drug Pricing Program Sustainability
1909 - Pharmacist Authority to Provide Medication-Assisted Treatment
1922 - Antimicrobial Use in Agriculture
*1803 - Confidence in the U.S. Drug Approval and Regulatory Process
1815 - Impact of Drug Litigation Ads on Patient Care
*1818 - Federal Quality Rating Program for Pharmaceutical Manufacturers
1819 - Intravenous Fluid Manufacturing Facilities as Critical Public Health Infrastructure
1713 - Partial Filling of Schedule II Prescriptions
1715 - Collaborative Practice
1716 - Greater Competition Among Generic and Biosimilar Manufacturers
1621 - Timely Board of Pharmacy Licensing.
1501 - Pharmacist Participation in Health Policy Development.